Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lukoil increases its stake in EL5-Energo

12/4/23 LKOH

X5 Reatail Group presented the concept of a new chain of Okolo stores

12/1/23 FIVE

Inter RAO reported for 9 months of 2023 by IFRS

12/1/23 IRAO

Sberbank has started developing its own anthropomorphic robots

12/1/23 SBER

Rosseti Moscow Region reported for 9 months of 2023 by IFRS

12/1/23 MSRS

Lenta opened a hypermarket Econom

12/1/23 LENT

Henderson's LFL sales for January-October were up 28.1%

12/1/23 HNFG

Mosgorlombard disclosed preliminary IPO parameters

12/1/23 MGKL

UGK launched the Vysokoye mine in the Krasnoyarsk region

12/1/23 UGLD

Sovcombank started collecting applications for participation in the IPO

12/1/23 SVCB